Increasing miR-16 expression might be a promising strategy for tumor therapy by repressing tumor angiogenesis and inducing tumor cell death through targeting VEGF and BCL2.42, 43 miR-17 is negative regulator of angiogenesis in ECs in vitro and in vivo. Here, VEGFA is linked to neoplasm.